Lipopolysaccharides from Escherichia coli O111:B4, purified by trichloroacetic acid extraction

Cat. No.: XGB676

Lipopolysaccharides from Escherichia coli O111:B4, purified by trichloroacetic acid extraction

Synonym: LPS

  • MDL: MFCD00164401
  • NACRES: NA.25
Product Size
100 mg;500 mg
Price
Datasheet
MSDS
Properties
Purity
purified by trichloroacetic acid extraction
Impurities
1-10% Protein (Lowry)
Biological Source
Escherichia coli (O111:B4)
Form
lyophilized powder
Quality Level
200
Applications
Lipopolysaccharides (LPSs) are characteristic components of the cell wall of Gram-negative bacteria. LPS and its lipid A part stimulate the cells of the innate immune system through Toll-like receptor 4 (TLR4), which can recognize common pathogen-related molecular patterns (PAMP). This LPS serotype has been used to stimulate B-cells and induce NOS in human hepatocytes.
Storage
2-8°C
Safety Information
WGK Germany
WGK 3
Hazard Statements
H300
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.